Analysis of cannabinoids and semi-synthetic cannabinoids in authentic breastmilk samples by liquid chromatography–tandem mass spectrometry
- 26 May 2025
- journal article
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 49 (8) , 559-566
Abstract
Marijuana (cannabis) is generally considered the most frequently misused substance during pregnancy. The prevalence in the use of either medical or non-medical marijuana for relief of pregnancy-related symptoms is increasing, as well as the use of cannabis-related products containing cannabidiol (CBD) and semi-synthetic cannabinoids (SSCs). Δ9-tetrahydrocannabinol (THC) and CBD are highly lipophilic substances and will readily pass into breastmilk upon ingestion. The solubility of THC and CBD in lipids poses significant analytical challenges in extracting and identifying these substances in breastmilk. The aim of this study was to develop a new and sensitive assay utilizing liquid chromatography–tandem mass spectrometry (LC–MS/MS) for the detection of cannabinoids in breastmilk. The method was optimized to quantitate Δ8-THC, Δ9–THC, cannabigerol (CBG), CBD, and cannabidiolic acid (CBDA) and validated with the guidance of the American Academy of Forensic Sciences Standards Board (ASB) Standard 036. The assay was then used to analyze breastmilk samples (N = 57) collected postpartum from female patients enrolled in a study assessing use behaviors of medical marijuana, non-medical marijuana, and CBD. All analytes passed validation criteria. Calibration curves for all analytes ranged 0.5–400 ng/mL, with the LOD and LLOQ of the method set at the lowest calibrator concentration. Δ9-THC was quantitated in 19 samples (33.3%) with a concentration range of 0.5–291 ng/mL. Δ8-THC was detected in one sample (1.8%) at 0.8 ng/mL, while CBD was observed in 3 samples at a concentration <LLOQ, and quantitated in only one sample (1.8%) also at a concentration of 0.8 ng/mL. CBG was detected in 7 samples (12.2%) with a concentration range of 0.6–12.9 ng/mL, and at a concentration <LLOQ in 12 samples. This study presents a sensitive method for the analysis of cannabinoids in breastmilk to support the follow-up assessments of marijuana and CBD use during pregnancy and postpartum.Keywords
Funding Information
- University of Florida Research Opportunity Seed Fund
This publication has 24 references indexed in Scilit:
- Quantitative analysis of Δ8- and Δ9-tetrahydrocannabinol metabolites and isomers: a rapid assay in urine by LC-MS/MSAnalytical and Bioanalytical Chemistry, 2025
- Simultaneous LC–MS/MS determination of 40 legal and illegal psychoactive drugs in breast and bovine milkFood Chemistry, 2018
- Analysis of cannabinoids by liquid chromatography–mass spectrometry in milk, liver and hemp seed to ensure food safetyFood Chemistry, 2017
- Trends in Marijuana Use Among Pregnant and Nonpregnant Reproductive-Aged Women, 2002-2014JAMA, 2017
- The Risks of Marijuana Use During PregnancyJAMA, 2017
- Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive ageAmerican Journal of Obstetrics and Gynecology, 2015
- Current knowledge on cannabinoids in oral fluidDrug Testing and Analysis, 2013
- Simultaneous analysis of frequently used licit and illicit psychoactive drugs in breast milk by liquid chromatography tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2011
- Human Cannabinoid PharmacokineticsChemistry & Biodiversity, 2007
- Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2003